跳至主要内容
临床试验/NCT00695032
NCT00695032暂停不适用

Biologic Evaluation of Renal Toxicity of Cisplatin and Ifosfamide (TOXIPLAT)

Institut Claudius Regaud2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2007年10月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
暂停
入组人数
80
试验地点
2
主要终点
Evolution of different biomarkers

研究概览

简要总结

RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is evaluating kidney damage in patients receiving cisplatin and ifosfamide for solid tumors.

详细描述

OBJECTIVES:

Primary

  • Identify and evaluate the early biomarkers of renal toxicity in patients with solid tumors treated with cisplatin and ifosfamide.

Secondary

  • Correlate the modification of biomarker studies and blood concentrations of cisplatin.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Evolution of different biomarkers

Sensitivity, specificity, and predictive value (positive and negative) of different markers

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验